SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-014397
Filing Date
2013-11-12
Accepted
2013-11-12 09:00:08
Documents
13
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ahro20130930_10q.htm 10-Q 857718
2 EXHIBIT 10.1 ex10-1.htm EX-10 78123
3 EXHIBIT 10.2 ex10-2.htm EX-10 65610
4 EXHIBIT 31.1 ex31-1.htm EX-31 17242
5 EXHIBIT 31.2 ex31-2.htm EX-31 17186
6 EXHIBIT 32.1 ex32-1.htm EX-32 6680
7 EXHIBIT 32.2 ex32-2.htm EX-32 7269
  Complete submission text file 0001437749-13-014397.txt   5587801

Data Files

Seq Description Document Type Size
8 EXHIBIT 101.INS ahro-20130930.xml EX-101.INS 712068
9 EXHIBIT 101.SCH ahro-20130930.xsd EX-101.SCH 45273
10 EXHIBIT 101.CAL ahro-20130930_cal.xml EX-101.CAL 27949
11 EXHIBIT 101.DEF ahro-20130930_def.xml EX-101.DEF 237129
12 EXHIBIT 101.LAB ahro-20130930_lab.xml EX-101.LAB 375921
13 EXHIBIT 101.PRE ahro-20130930_pre.xml EX-101.PRE 241488
Mailing Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612
Business Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612 (949) 525-5471
AtheroNova Inc. (Filer) CIK: 0001377053 (see all company filings)

IRS No.: 201915083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52315 | Film No.: 131207259
SIC: 2834 Pharmaceutical Preparations